Clinical Trial Update: Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Endometrial Hyperplasia [Phase 2]

View source ↗

Summary

Phase 2 trial investigating primary prevention and uterine preservation in premenopausal women with obesity and endometrial hyperplasia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Hyperplasia

Snippet

Sponsor: Washington University School of Medicine | Conditions: Endometrial Hyperplasia | Phase 2 | Status: WITHDRAWN